Amgen 2022: Operation growth strategy Issue Archives, October 2022, Therapeutics Amgen is equipped with a broad and diverse product portfolio, commercial capabilities, and levers for delivering mid-single digit revenue growth over this decade. Read more October 11, 2022/by Andrew Humphreys https://www.pharmalive.com/wp-content/uploads/2021/10/Otezla-30mg_single-Adjuested-PLive.jpg 879 700 Andrew Humphreys https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Andrew Humphreys2022-10-11 05:15:542022-10-05 09:48:23Amgen 2022: Operation growth strategy